NBIX
#645
Neurocrine Biosciences, Inc. - Common Stock
172.4 8 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.93%
Variación mensual
+7.87%
Variación en los últimos 6 meses
+27.54%
Cambio anual
+18.95%
Cierres anteriores
174.1 0
Open
172.4 7
Mínimo
172.2 8
High
173.1 8
Volumen
286
Financials
- Market Capitalization 17.34 B
- Employee 2 000
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
30.37
Relación precio/flujo de caja
5.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 510 |  TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.36 USD | -0.79% | -3.59% | +3.02% | +15.33% | 25.49 B USD | ||
| 616 |  VTRS Viatris Inc. - Common Stock | 16.37 USD | -0.12% | -4.04% | -1.39% | +58.16% | 19.06 B USD | ||
| 792 |  ELAN Elanco Animal Health Incorporated Common Stock | 25.26 USD | +0.44% | +2.14% | +2.14% | +12.79% | 12.62 B USD | ||
| 877 |  RDY Dr. Reddy's Laboratories Ltd | 12.82 USD | -0.77% | -12.55% | -4.26% | -12.61% | 10.70 B USD |